These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18363144

  • 1. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M.
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [Abstract] [Full Text] [Related]

  • 2. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 3. The influence of the extrusion die on pellet characteristics.
    Rabisková M, Weingartová D, Häring A.
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [Abstract] [Full Text] [Related]

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 5. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

  • 6. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR, Agrawal MK, Kumria R.
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [Abstract] [Full Text] [Related]

  • 7. The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor.
    Krejcová K, Rabisková M, Vetchý D, Polásek E, Tomásek V, Prokopová A.
    Drug Dev Ind Pharm; 2006 Jun; 32(5):585-93. PubMed ID: 16720413
    [Abstract] [Full Text] [Related]

  • 8. A protocol for the classification of wet mass in extrusion-spheronization.
    Gao Y, Hong Y, Xian J, Lin X, Shen L, Zhang X, Zhang N, Feng Y.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):996-1005. PubMed ID: 23563104
    [Abstract] [Full Text] [Related]

  • 9. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [Abstract] [Full Text] [Related]

  • 10. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 11. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 12. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA.
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [Abstract] [Full Text] [Related]

  • 13. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

  • 14. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight P.
    Pharm Dev Technol; 2006 Jan; 11(3):263-74. PubMed ID: 16895837
    [Abstract] [Full Text] [Related]

  • 15. Study of the influence of alkalizing components on matrix pellets prepared by extrusion/spheronization.
    Hamedelniel EI, Bajdik J, Kása P, Pintye-Hódi K.
    Pharm Dev Technol; 2012 Jan; 17(2):204-11. PubMed ID: 21067337
    [Abstract] [Full Text] [Related]

  • 16. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J, Rabisková M.
    Int J Pharm; 2002 Aug 21; 242(1-2):349-51. PubMed ID: 12176277
    [Abstract] [Full Text] [Related]

  • 17. New insights into the pelletization mechanism by extrusion/spheronization.
    Koester M, Thommes M.
    AAPS PharmSciTech; 2010 Dec 21; 11(4):1549-51. PubMed ID: 21042960
    [Abstract] [Full Text] [Related]

  • 18. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2014 Oct 21; 88(2):483-91. PubMed ID: 24950003
    [Abstract] [Full Text] [Related]

  • 19. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S, Heng PW, Liew CV.
    Pharm Dev Technol; 2013 Feb 21; 18(1):61-72. PubMed ID: 21981607
    [Abstract] [Full Text] [Related]

  • 20. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 21; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.